Z Kinderchir 1984, 39:46–49.PubMed 11. Jansen PL, Sturm E: Genetic cholestasis, causes and PI3K inhibitor consequences for hepatobiliary transport. Liver Int 2003, 23:315–322.PubMedCrossRef 12. Trauner M, Wagner M, Fickert P, Zollner G: Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 2005, 39:S111-S124.PubMedCrossRef 13. Paulusma CC, Kool M, Bosma PJ, Scheffer GL, ter Borg F, Scheper RJ, Tytgat GN, Borst P, Baas F, Oude Elferink RP: A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997, 25:1539–1542.PubMedCrossRef
14. Sookoian S, Castaño
G, Burgueño A, Gianotti TF, Pirola CJ: Association of the multidrug-resistance-associated protein gene CHIR-99021 in vitro {Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|buy Anti-infection Compound Library|Anti-infection Compound Library ic50|Anti-infection Compound Library price|Anti-infection Compound Library cost|Anti-infection Compound Library solubility dmso|Anti-infection Compound Library purchase|Anti-infection Compound Library manufacturer|Anti-infection Compound Library research buy|Anti-infection Compound Library order|Anti-infection Compound Library mouse|Anti-infection Compound Library chemical structure|Anti-infection Compound Library mw|Anti-infection Compound Library molecular weight|Anti-infection Compound Library datasheet|Anti-infection Compound Library supplier|Anti-infection Compound Library in vitro|Anti-infection Compound Library cell line|Anti-infection Compound Library concentration|Anti-infection Compound Library nmr|Anti-infection Compound Library in vivo|Anti-infection Compound Library clinical trial|Anti-infection Compound Library cell assay|Anti-infection Compound Library screening|Anti-infection Compound Library high throughput|buy Antiinfection Compound Library|Antiinfection Compound Library ic50|Antiinfection Compound Library price|Antiinfection Compound Library cost|Antiinfection Compound Library solubility dmso|Antiinfection Compound Library purchase|Antiinfection Compound Library manufacturer|Antiinfection Compound Library research buy|Antiinfection Compound Library order|Antiinfection Compound Library chemical structure|Antiinfection Compound Library datasheet|Antiinfection Compound Library supplier|Antiinfection Compound Library in vitro|Antiinfection Compound Library cell line|Antiinfection Compound Library concentration|Antiinfection Compound Library clinical trial|Antiinfection Compound Library cell assay|Antiinfection Compound Library screening|Antiinfection Compound Library high throughput|Anti-infection Compound high throughput screening| (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol 2008, 48:125–132.PubMedCrossRef 15. Oswald M, Kullak-Ublick GA, Paumgartner G, Beuers U: Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 2001, 21:247–253.PubMedCrossRef 16. Yamada T, Arai T, Nagino M, Oda K, Shoda J, Suzuki H, Sugiyama Y, Nimura Y: Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary HA-1077 cost cancer. Langenbecks Arch Surg 2005, 390:421–429.PubMedCrossRef 17. Fardel O, Jigorel E, Le Vee M, Payen L: Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed Pharmacother 2005, 59:104–114.PubMedCrossRef 18. Nies AT, Keppler D: The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 2007, 453:643–659.PubMedCrossRef
19. Wagner M, Zollner G, Trauner M: New molecular insights into the mechanisms of cholestasis. J Hepatol 2009, 51:565–580.PubMedCrossRef 20. Geier A, Wagner M, Dietrich CG, Trauner M: Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 2007, 1773:283–308.PubMedCrossRef 21. Denson LA, Auld KL, Schiek DS, McClure MH, Mangelsdorf DJ, Karpen SJ: Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 2000, 275:835–8843.CrossRef 22. Denson LA, Bohan A, Held MA, Boyer JL: Organ-specific alterations in RAR alpha: RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. Gastroenterology 2002, 123:599–607.PubMedCrossRef 23. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PL, Elferink RP: Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995, 269:G427-G434.PubMed 24.